Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Does my patient still need A long-acting inhaler? — PDC Rx
Soft-mist LAMA/LABA combination inhaler launched for COPD | MIMS online
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Long-Acting Muscarinic Antagonists (LAMAs) Fact Sheet | NHLBI, NIH
Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Key findings of recent LAMA and dual-agent LAMA/LABA trials reviewed. | Download Table
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Study design. Abbreviations: LAMA, long-acting muscarinic antagonist;... | Download Scientific Diagram
Study design schematic. Abbreviations: LABA, long-actingβ 2 -agonist;... | Download Scientific Diagram
study design. Abbreviations: laBa, long-acting β-2 agonist; laMa,... | Download Scientific Diagram
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
Study selection flow diagram. LABA, long-acting β 2 -agonist; LAMA,... | Download Scientific Diagram
Navigating New Treatment Options for COPD | Consultant360
Long-Acting Muscarinic Antagonists (LAMAs) Fact Sheet | NHLBI, NIH
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Follow-up treatment of COPD patients. Abbreviations: laMa, long-acting... | Download Scientific Diagram
